Cardinal Health (NYSE: CAH) delivered a decisive second-quarter beat on February 5, 2026, with non-GAAP EPS of $2.63, surpassing the $2.38 consensus estimate by 10.5%. ...

Key Takeaways CAH posted Q2 fiscal 2026 adjusted EPS of $2.63, beating estimates by 10% on 18.6% revenue growth.Cardinal Health saw profit growth across all segments, led by Pharmaceutical and Specialty Solutions.CAH raised fiscal 2026 EPS guidance to $10.15-$10.35, citing stronger segment performance.Cardinal Health, Inc. (CAH) reported second-quarter fiscal 2026 adjusted earnings per share (EPS) of $2.63, which beat the Zacks Consensus Estimate of $2.39 by 10%. The bottom line also improved 36.3% year ove ...

Cardinal Health Stock Roars Higher. Another Guidance Boost Can Do That. - Barron'sSkip to Main ContentThis copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.# Cardinal Health Stock Roars Higher. Another Guidance Boost Can Do That.By [Mackenzie Tatananni]ShareResize---ReprintsIn ...

Zurich Insurance's bid to buy British insurer Beazley will set the stage for further deals in the sector as buyers jostle for exposure to the lucrative specialty lines market, analysts, industry advis... ...

Cardinal Health (NYSE:CAH) Q2 2026 Earnings call February 05, 2026 08:30 AM ET Company ParticipantsAaron Alt - CFOCharles Rhyee - Managing DirectorElizabeth Anderson - Senior Managing DirectorEric Percher - Co-founderGlen Santangelo - Managing DirectorJason Hollar - CEOKevin Caliendo - Managing DirectorLisa Gill - Managing DirectorMatt Sims - VP and Head of Investor RelationsConference Call ParticipantsAllen Lutz - Senior Equity Research AnalystBrian Tanquilut - Senior Equity Research AnalystDaniel Grosslig ...

Cardinal Health (NYSE:CAH) Q2 2026 Earnings call February 05, 2026 08:30 AM ET Company ParticipantsAaron Alt - CFOCharles Rhyee - Managing DirectorElizabeth Anderson - Senior Managing DirectorEric Percher - Co-founderGlen Santangelo - Managing DirectorJason Hollar - CEOKevin Caliendo - Managing DirectorLisa Gill - Managing DirectorMatt Sims - VP and Head of Investor RelationsConference Call ParticipantsAllen Lutz - Senior Equity Research AnalystBrian Tanquilut - Senior Equity Research AnalystDaniel Grosslig ...

Cardinal Health (NYSE:CAH) Q2 2026 Earnings call February 05, 2026 08:30 AM ET Speaker3Hello, and welcome to the second quarter fiscal year 2026 Cardinal Health Incorporated Earnings Conference Call. My name is Sergei, and I will be your coordinator for today's event. Please note that this conference is being recorded, and for the duration of the call, your lines will be on a listen only. However, you will have the opportunity to ask questions at the end of the call. This can be done by pressing star one on ...

分组1 - Cardinal Health reported quarterly earnings of $2.63 per share, exceeding the Zacks Consensus Estimate of $2.39 per share, and up from $1.93 per share a year ago, representing an earnings surprise of +9.86% [1] - The company achieved revenues of $65.63 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.90%, and an increase from $55.26 billion year-over-year [2] - Cardinal has surpassed consensus EPS estimates in all four of the last quarters and has topped consensus revenue estimates two times during the same period [2] 分组2 - The stock's immediate price movement will depend on management's commentary during the earnings call and the sustainability of earnings expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $2.78 on revenues of $62.78 billion, and for the current fiscal year, it is $10.04 on revenues of $259.68 billion [7] - The Medical - Dental Supplies industry, to which Cardinal belongs, is currently ranked in the top 34% of over 250 Zacks industries, indicating a favorable outlook for the sector [8]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ................ to ...................... Commission File Number: 1-11373 Cardinal Health, Inc. (Exact name of registrant as specified in its chart ...

Q2 FY26 Earnings Cardinal Health, Inc. February 5, 2026 © 2026 Cardinal Health. All Rights Reserved. 1 © 2026 Cardinal Health. All Rights Reserved. • Q2 FY26 Earnings Cautions Concerning Forward-Looking Statements This presentation contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. These statements may be identified by words such as "expect," "anticipate," "intend," "plan," "believe," "will," "should," "c ...